We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
DD Adds Sterile Packaging Capacity at Costa Rica Manufacturing Plant
Read MoreHide Full Article
Key Takeaways
DD adds sterile packaging capabilities at its Costa Rica facility to serve global medical device demand.
The 16,000-sq-ft expansion includes new extrusion equipment and round-the-clock production lines.
DD becomes the first in Costa Rica and the Caribbean to produce sterile packaging for medical device use.
DuPont de Nemours, Inc. (DD - Free Report) announced an expansion of its sterile packaging operations by adding manufacturing capabilities at its Heredia, Costa Rica, plant. Enabling sterile packaging production at this healthcare manufacturing facility will help serve the global medical device industry and increase its existing medical tubing operations. Expanding the facility by 16,000 square feet has also helped DD serve the Caribbean and the Americas customers better.
The facility is running on a 24/7 production schedule to support customers’ demand with its ISO certified technical, assembly and packaging standards. The new expansion has been installed with additional extrusion equipment and production lines.
This expansion marks Costa Rica's first-ever production of sterile healthcare packaging. DD is the first in Costa Rica and the Caribbean to produce fluid management and sterile packaging offerings for the medical device industry.
DD is offering full and comprehensive solutions supporting healthcare applications, such as extruded tubing and subassemblies, advanced catheter assembly, medical balloons, skin contact devices, smart wearables, additive manufacturing, laser processing, precision injection-molding, medical device fabrication, machining and sterile packaging enabled by Tyvek.
DD stock has lost 13% over the past year compared with the industry’s 24.7% decline.
Image Source: Zacks Investment Research
For the second quarter of 2025, the company projects net sales of approximately $3.2 billion, operating EBITDA of around $815 million and adjusted earnings per share of about $1.05. This outlook reflects a seasonal sequential increase in sales. However, the rise is more subdued than previously anticipated due to timing shifts from the second quarter into the first quarter within the Semiconductor Technologies business.
The Zacks Consensus Estimate for Akzo Nobel’s current-year earnings is pegged at $1.66 per share, implying an 18.6% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters while missing once.
The Zacks Consensus Estimate for NEM’s current-year earnings is pegged at $4.18 per share, indicating a 20.1% year-over-year rise.Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed once, with an average surprise of 32.41%. NEM’s shares have gained 29.6% in the past year.
The Zacks Consensus Estimate for BCPC’s 2025 earnings is pegged at $5.15 per share, indicating a rise of 31% from year-ago levels. The company’s earnings beat the consensus estimate in two of the trailing four quarters while missing the rest. Its shares have gained 10.6% in the past year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
DD Adds Sterile Packaging Capacity at Costa Rica Manufacturing Plant
Key Takeaways
DuPont de Nemours, Inc. (DD - Free Report) announced an expansion of its sterile packaging operations by adding manufacturing capabilities at its Heredia, Costa Rica, plant. Enabling sterile packaging production at this healthcare manufacturing facility will help serve the global medical device industry and increase its existing medical tubing operations. Expanding the facility by 16,000 square feet has also helped DD serve the Caribbean and the Americas customers better.
The facility is running on a 24/7 production schedule to support customers’ demand with its ISO certified technical, assembly and packaging standards. The new expansion has been installed with additional extrusion equipment and production lines.
This expansion marks Costa Rica's first-ever production of sterile healthcare packaging. DD is the first in Costa Rica and the Caribbean to produce fluid management and sterile packaging offerings for the medical device industry.
DD is offering full and comprehensive solutions supporting healthcare applications, such as extruded tubing and subassemblies, advanced catheter assembly, medical balloons, skin contact devices, smart wearables, additive manufacturing, laser processing, precision injection-molding, medical device fabrication, machining and sterile packaging enabled by Tyvek.
DD stock has lost 13% over the past year compared with the industry’s 24.7% decline.
Image Source: Zacks Investment Research
For the second quarter of 2025, the company projects net sales of approximately $3.2 billion, operating EBITDA of around $815 million and adjusted earnings per share of about $1.05. This outlook reflects a seasonal sequential increase in sales. However, the rise is more subdued than previously anticipated due to timing shifts from the second quarter into the first quarter within the Semiconductor Technologies business.
DD’s Zacks Rank & Key Picks
DD currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Akzo Nobel N.V. (AKZOY - Free Report) , Newmont Corporation (NEM - Free Report) and Balchem Corporation (BCPC - Free Report) . While AKZOY and NEM currently sport a Zacks Rank #1 (Strong Buy) each, BCPC carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Akzo Nobel’s current-year earnings is pegged at $1.66 per share, implying an 18.6% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters while missing once.
The Zacks Consensus Estimate for NEM’s current-year earnings is pegged at $4.18 per share, indicating a 20.1% year-over-year rise.Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed once, with an average surprise of 32.41%. NEM’s shares have gained 29.6% in the past year.
The Zacks Consensus Estimate for BCPC’s 2025 earnings is pegged at $5.15 per share, indicating a rise of 31% from year-ago levels. The company’s earnings beat the consensus estimate in two of the trailing four quarters while missing the rest. Its shares have gained 10.6% in the past year.